- Home
- / Arbutus Biopharma
Arbutus Biopharma
Stock Price
$4
2024-10-29
Market Capitalization
$762.7 M
2024-10-29
Revenue
$14.1 M
FY, 2025
Arbutus Biopharma Summary
Company Summary
- Overview
- Arbutus Biopharma is a clinical-stage biopharmaceutical company that focuses on virology. It offers a pipeline focused on curing the hepatitis B virus.
- Type
- Public
- Status
- Active
- Founded
- 2005
- HQ
- Warminster, PA, US | view all locations
- Website
- http://www.arbutusbio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Karen Sims, Chief Medical Officer
David Hastings, Chief Financial Officer
Lisa Caperelli, Vice President, Investor Relations
LocationsView all
1 location detected
Warminster, PA HQ
United States
701 Veterans Cir
Arbutus Biopharma Financials
Summary Financials
- Revenue (Q1, 2026)
- $179.1M
- Net income (Q1, 2026)
- $169.7M
- Cash (Q1, 2026)
- $23.7M
- EBIT (Q1, 2026)
- $168.9M
- Enterprise value
- $739.6M